R. Atcher

The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy.

R. Weichselbaum, B. Block, M. Press, 1989, Gynecologic oncology.

The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma.

A. Herbst, J. Rotmensch, D. Grdina, 1989, American journal of obstetrics and gynecology.

Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry.

J. Schwartz, J. Rotmensch, D. Grdina, 1992, Gynecologic oncology.

The inherent cellular radiosensitivity of epithelial ovarian carcinoma.

J. Schwartz, J. Rotmensch, D. Grdina, 1989, Gynecologic oncology.

Comparison of short‐lived high‐LET α‐emitting radionuclides lead‐212 and bismuth‐212 to low‐LET X‐rays on ovarian carcinoma

J. Rotmensch, J. Hines, R. Atcher, 1989 .